Addressing progressive proximal muscle weakness and loss of motor function in patients with Limb-Girdle Muscular Dystrophy (LGMD) is undergoing a major shift toward disease-modifying genetic therapies. Detailed analysis within the Limb Girdle Muscular Dystrophy Market report outlines how adeno-associated virus (AAV) vector-mediated gene replacement, exon-skipping oligonucleotides, and...